ReP USP - Resultado da busca

Filtros : "FCF001" "FERNANDES, LIGIA PRESTES" Removidos: "Georgetown University – Lombardi Comprehensive Cancer Center, Washington, USA" "2025" Limpar

Filtros

USP affiliated authors
- barroso, lucia pereira (2)
- erger, inar castro (2)
- fernandes, ligia prestes (2)
- bertolami, adriana (1)
- fernandes, alan lins (1)

Artigo de periodico
The severity of COVID-19 upon hospital admission is associated with plasma omega-3 fatty acids (2024)
Fernandes, Lígia Prestes; Murai, Igor Hisashi; Fernandes, Alan Lins ; Sales, Lucas P; Rogero, Marcelo Macedo; Gualano, Bruno ; Barroso, Lucia Pereira ; Milne, Ginger L; Pereira, Rosa Maria Rodrigues ; Castro, Inar Alves de
Source: Scientific Reports. Unidades: FSP, FM, IME, FCF
Subjects: COVID-19, ÁCIDOS GRAXOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Lígia Prestes et al. The severity of COVID-19 upon hospital admission is associated with plasma omega-3 fatty acids. Scientific Reports, v. 14, p. 1-14 art. 10238, 2024Tradução . . Disponível em: https://dx.doi.org/10.1038/s41598-024-60815-y. Acesso em: 29 jun. 2024.
APA
Fernandes, L. P., Murai, I. H., Fernandes, A. L., Sales, L. P., Rogero, M. M., Gualano, B., et al. (2024). The severity of COVID-19 upon hospital admission is associated with plasma omega-3 fatty acids. Scientific Reports, 14, 1-14 art. 10238. doi:10.1038/s41598-024-60815-y
NLM
Fernandes LP, Murai IH, Fernandes AL, Sales LP, Rogero MM, Gualano B, Barroso LP, Milne GL, Pereira RMR, Castro IA de. The severity of COVID-19 upon hospital admission is associated with plasma omega-3 fatty acids [Internet]. Scientific Reports. 2024 ; 14 1-14 art. 10238.[citado 2024 jun. 29 ] Available from: https://dx.doi.org/10.1038/s41598-024-60815-y.
Vancouver
Fernandes LP, Murai IH, Fernandes AL, Sales LP, Rogero MM, Gualano B, Barroso LP, Milne GL, Pereira RMR, Castro IA de. The severity of COVID-19 upon hospital admission is associated with plasma omega-3 fatty acids [Internet]. Scientific Reports. 2024 ; 14 1-14 art. 10238.[citado 2024 jun. 29 ] Available from: https://dx.doi.org/10.1038/s41598-024-60815-y.
Artigo de periodico
Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? (2023)
Pimentel, Mariana Vieira de Mello Barros; Bertolami, Adriana; Fernandes, Lígia Prestes; Barroso, Lucia Pereira; Castro, Inar Alves de
Source: Biomedicine and Pharmacotherapy. Unidades: IDPC, IME, FCF
Subjects: BIOMARCADORES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Mariana Vieira de Mello Barros et al. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease?. Biomedicine and Pharmacotherapy, v. 160, p. 1-12 art. 114345, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2023.114345. Acesso em: 29 jun. 2024.
APA
Pimentel, M. V. de M. B., Bertolami, A., Fernandes, L. P., Barroso, L. P., & Castro, I. A. de. (2023). Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? Biomedicine and Pharmacotherapy, 160, 1-12 art. 114345. doi:10.1016/j.biopha.2023.114345
NLM
Pimentel MV de MB, Bertolami A, Fernandes LP, Barroso LP, Castro IA de. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? [Internet]. Biomedicine and Pharmacotherapy. 2023 ; 160 1-12 art. 114345.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.biopha.2023.114345
Vancouver
Pimentel MV de MB, Bertolami A, Fernandes LP, Barroso LP, Castro IA de. Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease? [Internet]. Biomedicine and Pharmacotherapy. 2023 ; 160 1-12 art. 114345.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.biopha.2023.114345

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024